These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22621168)

  • 1. Testing physical models of passive membrane permeation.
    Leung SS; Mijalkovic J; Borrelli K; Jacobson MP
    J Chem Inf Model; 2012 Jun; 52(6):1621-36. PubMed ID: 22621168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Membrane Permeation of Drug Molecules by Combining an Implicit Membrane Model with Machine Learning.
    Brocke SA; Degen A; MacKerell AD; Dutagaci B; Feig M
    J Chem Inf Model; 2019 Mar; 59(3):1147-1162. PubMed ID: 30540459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights into Passive Membrane Permeability of Drug-like Molecules from a Weighted Ensemble of Trajectories.
    Zhang S; Thompson JP; Xia J; Bogetti AT; York F; Skillman AG; Chong LT; LeBard DN
    J Chem Inf Model; 2022 Apr; 62(8):1891-1904. PubMed ID: 35421313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atomistic model of passive membrane permeability: application to a series of FDA approved drugs.
    Kalyanaraman C; Jacobson MP
    J Comput Aided Mol Des; 2007 Dec; 21(12):675-9. PubMed ID: 17989930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach.
    Chi CT; Lee MH; Weng CF; Leong MK
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes.
    Acharya C; Seo PR; Polli JE; Mackerell AD
    Mol Pharm; 2008; 5(5):818-28. PubMed ID: 18710255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affordable Membrane Permeability Calculations: Permeation of Short-Chain Alcohols through Pure-Lipid Bilayers and a Mammalian Cell Membrane.
    Tse CH; Comer J; Sang Chu SK; Wang Y; Chipot C
    J Chem Theory Comput; 2019 May; 15(5):2913-2924. PubMed ID: 30998342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple Predictive Models of Passive Membrane Permeability Incorporating Size-Dependent Membrane-Water Partition.
    Leung SS; Sindhikara D; Jacobson MP
    J Chem Inf Model; 2016 May; 56(5):924-9. PubMed ID: 27135806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A corneal-PAMPA-based in silico model for predicting corneal permeability.
    Vincze A; Dargó G; Rácz A; Balogh GT
    J Pharm Biomed Anal; 2021 Sep; 203():114218. PubMed ID: 34166924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?
    Swift RV; Amaro RE
    Chem Biol Drug Des; 2013 Jan; 81(1):61-71. PubMed ID: 23066853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance-dependent underprediction of in vivo intrinsic clearance from human hepatocytes: comparison with permeabilities from artificial membrane (PAMPA) assay, in silico and caco-2 assay, for 65 drugs.
    Hallifax D; Turlizzi E; Zanelli U; Houston JB
    Eur J Pharm Sci; 2012 Apr; 45(5):570-4. PubMed ID: 22214813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical QSAR Analysis of Passive Permeability Across Caco-2 Monolayers.
    Lanevskij K; Didziapetris R
    J Pharm Sci; 2019 Jan; 108(1):78-86. PubMed ID: 30321548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
    Kerns EH; Di L; Petusky S; Farris M; Ley R; Jupp P
    J Pharm Sci; 2004 Jun; 93(6):1440-53. PubMed ID: 15124203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Passive Permeability of Drug-like Molecules from Chemical Structure: Where Are We?
    Broccatelli F; Salphati L; Plise E; Cheong J; Gobbi A; Lee ML; Aliagas I
    Mol Pharm; 2016 Dec; 13(12):4199-4208. PubMed ID: 27806577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physics-Based Method for Modeling Passive Membrane Permeability and Translocation Pathways of Bioactive Molecules.
    Lomize AL; Pogozheva ID
    J Chem Inf Model; 2019 Jul; 59(7):3198-3213. PubMed ID: 31259555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the artificial membrane permeability of drugs by digital simulation.
    Nakamura M; Osakai T
    Eur J Pharm Sci; 2016 Aug; 91():154-61. PubMed ID: 27334569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel artificial membrane permeability assay (PAMPA) combined with a 10-day multiscreen Caco-2 cell culture as a tool for assessing new drug candidates.
    Masungi C; Mensch J; Van Dijck A; Borremans C; Willems B; Mackie C; Noppe M; Brewster ME
    Pharmazie; 2008 Mar; 63(3):194-9. PubMed ID: 18444507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.